Literature DB >> 31375779

Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects.

Ying Han1, Cheng-Yu Sun1,2, Shi-Qiu Meng1, Serik Tabarak3, Kai Yuan3, Lu Cao3, Wei Yan2, Ling-Zhi Xu1,2, Jia-Hui Deng2, Wei-Li Zhu1, Jia-Li Li1, Lin Lu4,5, Yan-Xue Xue6, Jie Shi7.   

Abstract

Immune dysregulation, specifically of inflammatory processes, has been linked to behavioral symptoms of depression in both human and rodent studies. Here, we evaluated the antidepressant effects of immunization with altered peptide ligands of myelin basic protein (MBP)-MBP87-99[A91, A96], MBP87-99[A91], and MBP87-99[R91, A96]-in different models of depression and examined the mechanism by which these peptides protect against stress-induced depression. We found that a single dose of subcutaneously administered MBP87-99[A91, A96] produced antidepressant-like effects by decreasing immobility in the forced swim test and by reducing the escape latency and escape failures in the learned helplessness paradigm. Moreover, immunization with MBP87-99[A91, A96] prevented and reversed depressive-like and anxiety-like behaviors that were induced by chronic unpredictable stress (CUS). However, MBP87-99[R91, A96] tended to aggravate CUS-induced anxiety-like behavior. Chronic stress increased the production of peripheral and central proinflammatory cytokines and induced the activation of microglia in the prelimbic cortex (PrL), which was blocked by MBP87-99[A91, A96]. Immunization with MBP-derived altered peptide ligands also rescued chronic stress-induced deficits in p11, phosphorylated cyclic adenosine monophosphate response element binding protein, and brain-derived neurotrophic factor expression. Moreover, microinjections of recombinant proinflammatory cytokines and the knockdown of p11 in the PrL blunted the antidepressant-like behavioral response to MBP87-99[A91, A96]. Altogether, these findings indicate that immunization with altered MBP peptide produces prolonged antidepressant-like effects in rats, and the behavioral response is mediated by inflammatory factors (particularly interleukin-6), and p11 signaling in the PrL. Immune-neural interactions may impact central nervous system function and alter an individual's response to stress.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31375779     DOI: 10.1038/s41380-019-0470-9

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  82 in total

1.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Authors:  C Y Cheung; L L M Poon; A S Lau; W Luk; Y L Lau; K F Shortridge; S Gordon; Y Guan; J S M Peiris
Journal:  Lancet       Date:  2002-12-07       Impact factor: 79.321

2.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

3.  Th1, Th2, and Th3 cytokine alterations in major depression.

Authors:  Aye-Mu Myint; Brian E Leonard; Harry W M Steinbusch; Yong-Ku Kim
Journal:  J Affect Disord       Date:  2005-10       Impact factor: 4.839

Review 4.  Cytokines sing the blues: inflammation and the pathogenesis of depression.

Authors:  Charles L Raison; Lucile Capuron; Andrew H Miller
Journal:  Trends Immunol       Date:  2005-11-28       Impact factor: 16.687

5.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

6.  A meta-analysis of cytokines in major depression.

Authors:  Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

7.  Rapid antidepressant effects: moving right along.

Authors:  K Martinowich; D V Jimenez; C A Zarate; H K Manji
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

Review 8.  Neuroimmune mechanisms of depression.

Authors:  Georgia E Hodes; Veronika Kana; Caroline Menard; Miriam Merad; Scott J Russo
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

9.  Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy.

Authors:  Levent Sutcigil; Cagatay Oktenli; Ugur Musabak; Ali Bozkurt; Adnan Cansever; Ozcan Uzun; S Yavuz Sanisoglu; Zeki Yesilova; Nahit Ozmenler; Aytekin Ozsahin; Ali Sengul
Journal:  Clin Dev Immunol       Date:  2007

10.  Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.

Authors:  J C Felger; Z Li; E Haroon; B J Woolwine; M Y Jung; X Hu; A H Miller
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

View more
  2 in total

1.  Neurocan regulates vulnerability to stress and the anti-depressant effect of ketamine in adolescent rats.

Authors:  Zhoulong Yu; Ying Han; Die Hu; Na Chen; Zhongyu Zhang; Wenxi Chen; Yanxue Xue; Shiqiu Meng; Lin Lu; Wen Zhang; Jie Shi
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

2.  Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation.

Authors:  Zhong Wang; Wen-Hao Chen; Su-Xia Li; Zhong-Ming He; Wei-Li Zhu; Yan-Bin Ji; Zhe Wang; Xi-Mei Zhu; Kai Yuan; Yan-Ping Bao; Le Shi; Shi-Qiu Meng; Yan-Xue Xue; Wen Xie; Jie Shi; Wei Yan; Hong Wei; Lin Lu; Ying Han
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.